GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 12-1999 | 12-1998 | 12-1997 | 12-1996 | |
| Sales | 3,540 | 7,160 | 5,140 | 5,050 | 4,860 |
| Cost of Goods | 3,059 | 5,880 | 4,210 | 3,200 | 3,000 |
| Gross Profit | 481 | 1,270 | 930 | 1,650 | 1,793 |
| Operating Expenses | 5,266 | 6,560 | 8,130 | 200 | 0 |
| Operating Income | -4,726 | -4,400 | -6,990 | 1,850 | 1,860 |
| Interest Expense | 90 | 90 | 290 | 150 | 130 |
| Other Income | 180 | 50 | 160 | -6,851 | -7,722 |
| Pre-tax Income | -4,636 | -4,440 | -7,120 | -5,151 | -5,992 |
| Net Income Continuous | -4,636 | -4,447 | -7,120 | -5,151 | -5,992 |
| Net Income | $-4,636 | $-4,440 | $-7,120 | $-5,150 | $-5,990 |
| EPS Basic Total Ops | -0.50 | -21,666,690.00 | -1,309,137.00 | -1,996,238.00 | -3,107,349.00 |
| EPS Basic Continuous Ops | -0.50 | -21,700,850.00 | -1,309,137.00 | -1,996,626.00 | -3,108,387.00 |
| EPS Diluted Total Ops | -0.50 | -21,666,690.00 | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | -0.50 | -21,700,850.00 | N/A | N/A | N/A |
| EBITDA(a) | $-4,283 | $-3,570 | $-5,440 | $3,070 | $3,240 |